prostatic cancer
Conditions
Interventions
Experimental group :During the neoadjuvant treatment period, subjects were intramuscularly injected with Goserellin microspheres: 3.6mg, once a month, and orally administered NHA (unspecified drug) fo
Sponsors
The First Affiliated Hospital of Xinjiang Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age = 18 years old 2. Pathological diagnosis of prostate cancer 3. Clinical staging of T2c-T4NxM0 with Gleason ps>7 4. Planned neoadjuvant therapy combined with radical prostatectomy according to guidelines 5. ECOG score = 1 point 6. No other medication treatment received
Exclusion criteria
Exclusion criteria: 1. Pathological diagnosis of urinary tract epithelial origin; 2. Pathological diagnosis of neuroendocrine tumor; 3. Pathological diagnosis of intraductal carcinoma; 4. Received any other anti-tumor treatment 6 months prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pathologic complete response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive margin rate;disease-free survival;overall survival;adverse reactions; | — |
Countries
China
Contacts
Public ContactQianjin Li
The First Affiliated Hospital of Xinjiang Medical University
Outcome results
None listed